spironolactone has been researched along with Pemphigoid, Bullous in 3 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The role of spironolactone as pemphigoid-inducing agent has recently been suggested." | 7.71 | [Bullous pemphigoid induced by spironolactone]. ( Cordel, N; Courville, P; Gilbert, D; Joly, P; Lauret, P; Modeste, AB, 2002) |
| "The causal effect of spironolactone in this case of pemphigoid is quite plausible." | 7.69 | [Spironolactone-induced pemphigoid]. ( Grange, F; Guillaume, JC; Koessler, A; Scrivener, Y; Straub, P, 1997) |
| "The role of spironolactone as pemphigoid-inducing agent has recently been suggested." | 3.71 | [Bullous pemphigoid induced by spironolactone]. ( Cordel, N; Courville, P; Gilbert, D; Joly, P; Lauret, P; Modeste, AB, 2002) |
| "The causal effect of spironolactone in this case of pemphigoid is quite plausible." | 3.69 | [Spironolactone-induced pemphigoid]. ( Grange, F; Guillaume, JC; Koessler, A; Scrivener, Y; Straub, P, 1997) |
| "86), and chronic use of spironolactone (OR, 2." | 1.37 | Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. ( Bastuji-Garin, S; Bedane, C; Bernard, P; Delaporte, E; Dutronc, Y; Guillaume, JC; Ingen-Housz-Oro, S; Joly, P; Lemordant, P; Maillard, H; Pauwels, C; Picard-Dahan, C; Richard, MA; Roujeau, JC; Sparsa, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastuji-Garin, S | 1 |
| Joly, P | 2 |
| Lemordant, P | 1 |
| Sparsa, A | 1 |
| Bedane, C | 1 |
| Delaporte, E | 1 |
| Roujeau, JC | 1 |
| Bernard, P | 1 |
| Guillaume, JC | 2 |
| Ingen-Housz-Oro, S | 1 |
| Maillard, H | 1 |
| Pauwels, C | 1 |
| Picard-Dahan, C | 1 |
| Dutronc, Y | 1 |
| Richard, MA | 1 |
| Grange, F | 1 |
| Scrivener, Y | 1 |
| Koessler, A | 1 |
| Straub, P | 1 |
| Modeste, AB | 1 |
| Cordel, N | 1 |
| Courville, P | 1 |
| Gilbert, D | 1 |
| Lauret, P | 1 |
3 other studies available for spironolactone and Pemphigoid, Bullous
| Article | Year |
|---|---|
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Bed Rest; Bipolar Disorder; Case-Control Studies; Cog | 2011 |
[Spironolactone-induced pemphigoid].
Topics: Aged; Aged, 80 and over; Diuretics; Female; Humans; Pemphigoid, Bullous; Spironolactone; Thigh | 1997 |
[Bullous pemphigoid induced by spironolactone].
Topics: Aged; Biopsy; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Eruptions; Drug Therapy, Combin | 2002 |